查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612955

霍亂疫苗市場：按類型、管理方法、最終用戶、年齡層別分類 - 全球預測 2025-2030

Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines), End User, Age Group - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年霍亂疫苗市值為2.8642億美元，預計2024年將達到3.0702億美元，複合年成長率為7.32%，到2030年將達到4.6983億美元。

霍亂疫苗在減輕流行全部區域霍亂疫情的影響方面發揮重要作用。疫苗市場包括Dukoral、Shanchol、Euvichol等口服疫苗，主要針對開發中國家、旅客、疫情地區的高風險族群。清潔水和衛生設施的取得有限，以及膽道疾病的持續爆發，增加了對這些疫苗的需求。疫苗主要用於流行病免疫和高風險地區的常規管理，最終用途廣泛，包括公共衛生機構、非政府組織和國際免疫計畫。市場成長是由意識增強、政府措施、國際資金籌措和新興疫苗技術所推動的。最近，開發更具成本效益和更持久的疫苗的潛力為製造商與衛生組織合作並擴大其分銷網路創造了機會。然而，物流挑戰、低溫運輸限制以及人口稀少地區的意識低等限制是市場擴張的主要障礙。此外，某些國家的政治不穩定和監管核准可能會對市場的持續成長構成挑戰。為了利用成長機會，公司應該在耐熱配方、免疫抗原性和單劑量方案等領域進行創新，以減少後勤負擔。重組口服疫苗的研究和霍亂 mRNA 平台的探索可能會改變預防策略。市場滲透需要多樣化且價格實惠的產品系列以及與公共衛生機構的策略合作夥伴關係。市場仍然充滿活力，定期爆發會導致需求激增，營運商需要靈活應對這些波動。了解當地疾病負擔和未滿足的需求可以引導成功的市場進入並確保在當前挑戰下實現持續成長。

主要市場統計
基準年[2023] 2.8642億美元
預測年份 [2024] 30702萬美元
預測年份 [2030] 46983萬美元
複合年成長率（%） 7.32%

市場動態：快速發展的霍亂疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變霍亂疫苗市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球霍亂病例數不斷增加
    • 政府支持霍亂疫苗接種宣傳活動
  • 市場限制因素
    • 疫苗研發成本高及產品短缺問題
  • 市場機會
    • 重組DNA技術與細胞生產系統的開發
    • 霍亂疫苗包裝與儲存解決方案的創新
  • 市場挑戰
    • 全球缺乏熟練的醫療保健專業人員

波特的五力：駕馭霍亂疫苗市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解霍亂疫苗市場的外部影響

外部宏觀環境因素對霍亂疫苗市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解霍亂疫苗市場的競爭狀況

霍亂疫苗市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣霍亂疫苗市場供應商的績效評估

FPNV定位矩陣是評估霍亂疫苗市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製霍亂疫苗市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，霍亂疫苗市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地霍亂感染人數不斷增加
      • 政府支持霍亂疫苗接種的廣告宣傳活動
    • 抑制因素
      • 疫苗研發高成本、產品短缺問題
    • 機會
      • 重組 DNA 技術與細胞生產系統的進展
      • 霍亂疫苗包裝與儲存解決方案的創新
    • 任務
      • 全球缺乏熟練的醫療保健專業人員
  • 市場區隔分析
    • 類型：減毒疫苗的採用率很高，因為它們能夠刺激強烈的免疫反應
    • 最終用戶：政府免疫計畫變得越來越重要，重點是教育人們霍亂預防方法和疫苗接種的重要性。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章霍亂疫苗市場：依類型

  • 去活化疫苗
  • 減毒活疫苗

第7章 依給藥方式分類的霍亂疫苗市場

  • 注射疫苗
  • 口服疫苗

第8章霍亂疫苗市場：依最終用戶分類

  • 政府疫苗接種計劃
  • 醫院/診所

第9章霍亂疫苗市場：依年齡層

  • 成人
  • 孩子們

第10章美洲霍亂疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區霍亂疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲的霍亂疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 霍亂疫苗接種策略技術轉移：IVI 與 Biological E. Limited 之間的合作
    • GC Biopharma 與 Eubiologics 就霍亂疫苗生產建立策略聯盟
    • TechInvention 與 Eubiologics 合作在印度推出創新霍亂疫苗包裝
  • 戰略分析和建議

公司名單

  • Astellas Pharma Inc.
  • Beijing Minhai Biological Technology Co., Ltd.
  • Bharat Biotech Ltd.
  • Bio-Manguinhos
  • Biological E Ltd
  • BioVac by Ceva Sante Animale
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Haffkine Bio-Pharmaceutical Corporation Ltd
  • Incepta Pharmaceuticals Ltd.
  • Merck & Co. Inc
  • Panacea Biotec Ltd
  • Sanofi SA
  • SK Inc.
  • Techinvention Lifecare Pvt. Ltd.
  • Valneva SE
Product Code: MRR-5D693B46BD1B

The Cholera Vaccines Market was valued at USD 286.42 million in 2023, expected to reach USD 307.02 million in 2024, and is projected to grow at a CAGR of 7.32%, to USD 469.83 million by 2030.

Cholera vaccines play a critical role in mitigating the impact of cholera outbreaks across endemic regions. The vaccine market encompasses oral vaccines such as Dukoral, Shanchol, and Euvichol, primarily targeting high-risk populations in developing countries, travelers, and regions experiencing outbreaks. There's a rising necessity for these vaccines driven by persistent choleral outbreaks due to limited access to clean water and sanitation. The application of vaccines mainly spans prophylactic immunization during epidemics and routine administration in high-risk areas, with end-use across public health agencies, NGOs, and international vaccination programs. Market growth is propelled by increased awareness, government initiatives, international funding, and emerging vaccine technologies. Recently, there is potential for cost-effective, longer-lasting vaccines, fostering opportunities for manufacturers to partner with health organizations to expand distribution networks. Nevertheless, limitations include logistical challenges, cold chain constraints, and a lack of awareness in underdeveloped areas which pose as significant barriers to market expansion. Additionally, political instability and regulatory approvals in certain countries can challenge consistent market growth. To capitalize on growth opportunities, businesses should innovate in fields like thermostable formulations, enhanced immunogenicity, and single-dose regimens to reduce logistical burdens. Research into genetically engineered oral vaccines and exploring the mRNA platform for cholera could transform prevention strategies. A diverse, affordable product portfolio and strategic collaborations with public health agencies are necessary for market penetration. The market remains dynamic with periodic demand spikes driven by outbreaks, and operators must stay agile to respond to these fluctuations. Understanding regional disease burden and unmet needs can guide successful market entries and ensure sustainable growth despite current challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 286.42 million
Estimated Year [2024] USD 307.02 million
Forecast Year [2030] USD 469.83 million
CAGR (%) 7.32%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cholera Vaccines Market

The Cholera Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of cholera cases across the globe
    • Supportive government promotional campaigns for cholera vaccination
  • Market Restraints
    • High cost of vaccine development coupled with issues of product shortages
  • Market Opportunities
    • Developments in recombinant DNA technology and cell-based production systems
    • Innovations in packaging and storage solutions for cholera vaccines
  • Market Challenges
    • Limited availability of skilled healthcare professionals worldwide

Porter's Five Forces: A Strategic Tool for Navigating the Cholera Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cholera Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cholera Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cholera Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cholera Vaccines Market

A detailed market share analysis in the Cholera Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cholera Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cholera Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cholera Vaccines Market

A strategic analysis of the Cholera Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cholera Vaccines Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Beijing Minhai Biological Technology Co., Ltd., Bharat Biotech Ltd., Bio-Manguinhos, Biological E Ltd, BioVac by Ceva Sante Animale, Emergent BioSolutions Inc., GlaxoSmithKline plc, Haffkine Bio-Pharmaceutical Corporation Ltd, Incepta Pharmaceuticals Ltd., Merck & Co. Inc, Panacea Biotec Ltd, Sanofi S.A., SK Inc., Techinvention Lifecare Pvt. Ltd., and Valneva SE.

Market Segmentation & Coverage

This research report categorizes the Cholera Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Inactivated Vaccine and Live Attenuated Vaccine.
  • Based on Method of Administration, market is studied across Injectable Vaccines and Oral Vaccines.
  • Based on End User, market is studied across Government Vaccination Programs and Hospitals & Clinics.
  • Based on Age Group, market is studied across Adults and Children.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cholera cases across the globe
      • 5.1.1.2. Supportive government promotional campaigns for cholera vaccination
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of vaccine development coupled with issues of product shortages
    • 5.1.3. Opportunities
      • 5.1.3.1. Developments in recombinant DNA technology and cell-based production systems
      • 5.1.3.2. Innovations in packaging and storage solutions for cholera vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled healthcare professionals worldwide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Higher adoption of attenuated vaccines owing to their ability to stimulate strong immune responses
    • 5.2.2. End User: Growing significance of Government vaccination programs, focusing on educating people about cholera prevention methods and the importance of vaccination
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cholera Vaccines Market, by Type

  • 6.1. Introduction
  • 6.2. Inactivated Vaccine
  • 6.3. Live Attenuated Vaccine

7. Cholera Vaccines Market, by Method of Administration

  • 7.1. Introduction
  • 7.2. Injectable Vaccines
  • 7.3. Oral Vaccines

8. Cholera Vaccines Market, by End User

  • 8.1. Introduction
  • 8.2. Government Vaccination Programs
  • 8.3. Hospitals & Clinics

9. Cholera Vaccines Market, by Age Group

  • 9.1. Introduction
  • 9.2. Adults
  • 9.3. Children

10. Americas Cholera Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cholera Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cholera Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Strategic Technology Transfer in Cholera Vaccination: A Partnership Between IVI and Biological E. Limited
    • 13.3.2. Strategic Collaboration for Cholera Vaccine Production between GC Biopharma and Eubiologics
    • 13.3.3. TechInvention Introduces Innovative Cholera Vaccine Packaging in India with Eubiologics Partnership
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Astellas Pharma Inc.
  • 2. Beijing Minhai Biological Technology Co., Ltd.
  • 3. Bharat Biotech Ltd.
  • 4. Bio-Manguinhos
  • 5. Biological E Ltd
  • 6. BioVac by Ceva Sante Animale
  • 7. Emergent BioSolutions Inc.
  • 8. GlaxoSmithKline plc
  • 9. Haffkine Bio-Pharmaceutical Corporation Ltd
  • 10. Incepta Pharmaceuticals Ltd.
  • 11. Merck & Co. Inc
  • 12. Panacea Biotec Ltd
  • 13. Sanofi S.A.
  • 14. SK Inc.
  • 15. Techinvention Lifecare Pvt. Ltd.
  • 16. Valneva SE

LIST OF FIGURES

  • FIGURE 1. CHOLERA VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. CHOLERA VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CHOLERA VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CHOLERA VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHOLERA VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHOLERA VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHOLERA VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHOLERA VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHOLERA VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHOLERA VACCINES MARKET SIZE, BY INJECTABLE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ORAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHOLERA VACCINES MARKET SIZE, BY GOVERNMENT VACCINATION PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHOLERA VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CHOLERA VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CHOLERA VACCINES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CHOLERA VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CHOLERA VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY METHOD OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CHOLERA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 187. CHOLERA VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 188. CHOLERA VACCINES MARKET, FPNV POSITIONING MATRIX, 2023